Literature DB >> 19399601

The profile of prostate epithelial cytokines and its impact on sera prostate specific antigen levels.

Yosra Bouraoui Mechergui1, Awatef Ben Jemaa, Chekib Mezigh, Benito Fraile, Nawfel Ben Rais, Ricardo Paniagua, Mar Royuela, Ridha Oueslati.   

Abstract

The aim of this study was determined the expression of pro inflammatory cytokines in prostate epithelial cells. Furthermore, we analysed the relation between these cytokines and sera PSA levels according the three groups: 0-4, 4-20 and >20 ng/mL. The study was carried out in five normal prostate (NP), 27 benign prostate hyperplastic (BPH) and 18 prostate cancer (PC). Immunohistochemical and Western blot analysis was performed. Serum levels of PSA were assayed by Immulite autoanalyser. The western Blotting analysis revealed an immunoexpression of IL-1alpha, IL-6 and TNFalpha in BPH and PC. IL-1alpha, was absent in NP. Immunohistochemical analysis showed significant high optical density to IL-1alpha and IL-6 in cancer epithelial cells (19.45 +/- 3.25 and 26.2 +/- 3.19) compared to normal cells (1.73 +/- 1.51 and 4.83 +/- 2.65). While, TNFalpha optical densities were not significant in NP (12.03 +/- 2.9), BPH (9.87 +/- 3.85) and PC (13.34 +/- 2.34). The different profiles of cytokines according sera PSA levels showed a high immunoexpression of the profile (IL-6+, IL-1alpha+) in BPH patients with PSA between 0-4 and 4-20 ng/mL. However, PC patients with sera PSA between 4 and 20 ng/mL, showed a significant high immunoexpression of the profile (IL-6+, IL-1alpha-). This data demonstrate a locally production of pro-inflammatory cytokines by prostate epithelial cells and a cross talk between PSA and these cytokines in prostate pathologies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19399601     DOI: 10.1007/s10753-009-9121-7

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  43 in total

Review 1.  Proinflammatory cytokines.

Authors:  C A Dinarello
Journal:  Chest       Date:  2000-08       Impact factor: 9.410

Review 2.  Paradoxical roles of the immune system during cancer development.

Authors:  Karin E de Visser; Alexandra Eichten; Lisa M Coussens
Journal:  Nat Rev Cancer       Date:  2006-01       Impact factor: 60.716

3.  Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.

Authors:  W J Catalona; A W Partin; K M Slawin; M K Brawer; R C Flanigan; A Patel; J P Richie; J B deKernion; P C Walsh; P T Scardino; P H Lange; E N Subong; R E Parson; G H Gasior; K G Loveland; P C Southwick
Journal:  JAMA       Date:  1998-05-20       Impact factor: 56.272

4.  Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue.

Authors:  A Hobisch; H Rogatsch; A Hittmair; D Fuchs; G Bartsch; H Klocker; G Bartsch; Z Culig
Journal:  J Pathol       Date:  2000-07       Impact factor: 7.996

5.  Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis.

Authors:  S F Shariat; B Andrews; M W Kattan; J Kim; T M Wheeler; K M Slawin
Journal:  Urology       Date:  2001-12       Impact factor: 2.649

Review 6.  The biology of hormone refractory prostate cancer. Why does it develop?

Authors:  J T Isaacs
Journal:  Urol Clin North Am       Date:  1999-05       Impact factor: 2.241

7.  Correlation of histological inflammation in needle biopsy specimens with serum prostate- specific antigen levels in men with negative biopsy for prostate cancer.

Authors:  K Okada; M Kojima; Y Naya; K Kamoi; K Yokoyama; T Takamatsu; T Miki
Journal:  Urology       Date:  2000-06       Impact factor: 2.649

8.  Requirement for NF-(kappa)B in interleukin-4-induced androgen receptor activation in prostate cancer cells.

Authors:  Soo Ok Lee; Wei Lou; Nagalakshmi Nadiminty; Xin Lin; Allen C Gao
Journal:  Prostate       Date:  2005-07-01       Impact factor: 4.104

9.  An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines.

Authors:  Miltiadis Paliouras; Eleftherios P Diamandis
Journal:  Biol Chem       Date:  2008-06       Impact factor: 3.915

10.  Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer.

Authors:  V Michalaki; K Syrigos; P Charles; J Waxman
Journal:  Br J Cancer       Date:  2004-06-14       Impact factor: 7.640

View more
  12 in total

Review 1.  Role of interleukins, IGF and stem cells in BPH.

Authors:  Ian D McLaren; Travis J Jerde; Wade Bushman
Journal:  Differentiation       Date:  2011-08-23       Impact factor: 3.880

2.  Intrinsic fluorescence of protoporphyrin IX from blood samples can yield information on the growth of prostate tumours.

Authors:  Flávia Rodrigues de Oliveira Silva; Maria Helena Bellini; Vivian Regina Tristão; Nestor Schor; Nilson Dias Vieira; Lilia Coronato Courrol
Journal:  J Fluoresc       Date:  2010-04-24       Impact factor: 2.217

3.  The proinflammatory cytokine, IL-6, and its interference with bFGF signaling and PSMA in prostate cancer cells.

Authors:  Awatef Ben Jemaa; Sataa Sallami; Dunia Ramarli; Marco Colombatti; Ridha Oueslati
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

4.  A bioengineered organotypic prostate model for the study of tumor microenvironment-induced immune cell activation.

Authors:  Sheena C Kerr; Molly M Morgan; Amani A Gillette; Megan K Livingston; Karina M Lugo-Cintron; Peter F Favreau; Logan Florek; Brian P Johnson; Joshua M Lang; Melissa C Skala; David J Beebe
Journal:  Integr Biol (Camb)       Date:  2020-10-16       Impact factor: 3.177

5.  Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer.

Authors:  Jennifer S Myers; Ariana K von Lersner; Charles J Robbins; Qing-Xiang Amy Sang
Journal:  PLoS One       Date:  2015-12-18       Impact factor: 3.240

6.  Effects of concentrated long-chain omega-3 polyunsaturated fatty acid supplementation before radical prostatectomy on prostate cancer proliferation, inflammation, and quality of life: study protocol for a phase IIb, randomized, double-blind, placebo-controlled trial.

Authors:  Marie-Hélène Guertin; Karine Robitaille; Jean-François Pelletier; Thierry Duchesne; Pierre Julien; Josée Savard; Isabelle Bairati; Vincent Fradet
Journal:  BMC Cancer       Date:  2018-01-10       Impact factor: 4.430

7.  High miR-205 expression in normal epithelium is associated with biochemical failure - an argument for epithelial crosstalk in prostate cancer?

Authors:  Yngve Nordby; Elin Richardsen; Nora Ness; Tom Donnem; Hiten R H Patel; Lill-Tove Busund; Roy M Bremnes; Sigve Andersen
Journal:  Sci Rep       Date:  2017-11-24       Impact factor: 4.379

Review 8.  P. acnes-Driven Disease Pathology: Current Knowledge and Future Directions.

Authors:  Joerg R Leheste; Kathryn E Ruvolo; Joanna E Chrostowski; Kristin Rivera; Christopher Husko; Alyssa Miceli; Martin K Selig; Holger Brüggemann; German Torres
Journal:  Front Cell Infect Microbiol       Date:  2017-03-14       Impact factor: 5.293

9.  Upregulated Interleukin 21 Receptor Enhances Proliferation and Epithelial-Mesenchymal Transition Process in Benign Prostatic Hyperplasia.

Authors:  Deqiang Xu; Ping Chen; He Xiao; Xinghuan Wang; Michael E DiSanto; Xinhua Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-23       Impact factor: 5.555

10.  A Network Biology Approach Identifies Molecular Cross-Talk between Normal Prostate Epithelial and Prostate Carcinoma Cells.

Authors:  Victor Trevino; Alberto Cassese; Zsuzsanna Nagy; Xiaodong Zhuang; John Herbert; Philipp Antczak; Kim Clarke; Nicholas Davies; Ayesha Rahman; Moray J Campbell; Michele Guindani; Roy Bicknell; Marina Vannucci; Francesco Falciani
Journal:  PLoS Comput Biol       Date:  2016-04-28       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.